GH Research (FRA:1KA) GF Score: 35/100 (As of Jul. 04, 2026) — 59% Above Median


FRA:1KA GH Research PLC FRA:1KA
35 GF Score
Price €23.20
! 2 Warning Signs
View Full Analysis

What is GH Research GF Score?

GH Research FRA:1KA +1.75% 35 GF Score is 35 as of Jul. 04, 2026, which is 59% above its 10-year median of 22.00. GuruFocus rates FRA:1KA with a GF Score™ of 35/100. The stock has 2 warning signs investors should review.

GH Research has the GF Score of 35, which implies that the company might have Worst future performance potential, or not enough data.

The GF Score is a stock performance ranking system developed by GuruFocus using five aspects of valuation, which has been found to be closely correlated to the long-term performances of stocks by backtesting from 2006 to 2021. The stocks with a higher GF Score generally generate higher returns than those with lower GF Scores. Therefore, when picking stocks, investors should invest in companies with high GF Scores. The GF Score ranges from 0 to 100, with 100 as the highest rank.

GF Score takes following five key aspects into consideration:

1. Financial Strength : 8/10
2. Profitability Rank : 1/10
3. Growth Rank : 0/10
4. GF Value Rank : 0/10
5. Momentum Rank : 9/10

Each one of these components is ranked and the ranks also have positive correlation with the long term performances of stocks. The GF score is calculated using the five key aspects of analysis. Through backtesting, we know that each of these key aspects has a different impact on the stock price performance. Thus, they are weighted differently when calculating the total score. The Profitability Rank and the Growth Rank are weighted fully, while other parameters have less weight.

Based on research and backtesting result, GuruFocus believes GH Research might have Worst future performance potential, or not enough data.

Please click GF Score to see more details on the GF Score's 5 Key Aspects of Analysis.

GH Research  (FRA:1KA) GF Score Explanation

Based on the historical long-term performances among five valuation aspects, the GF Score is found to be closely correlated to the long-term performances of stocks. It ranges from 0 to 100, with 100 as the highest. GuruFocus divided GF Score into following 5 categories:

GF Score Performance Potential and All-in-One Screener Examples (1)
91 - 100Highest outperformance potential
81 - 90Good outperformance potential
71 - 80Likely to have average performance
51 - 70Poor future performance potential
0 - 50Worst future performance potential, or not enough data

(1) These are some simple examples. You can access our GF Score filter under All-in-One Screener’s Fundamental tab.

GH Research GF Score Related Terms

FRA:1KA vs ATAI, RAPP, NUVB: GF Score Comparison

For the Biotechnology subindustry, GH Research's GF Score, along with its competitors' market caps and GF Score data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

GH Research GF Score vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, GH Research's GF Score distribution charts can be found below:

* The bar in red indicates where GH Research's GF Score falls into.


FRA:1KA
35GF Score
GH Research PLC FRA:1KA
GF Score is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis
Frequently Asked Questions Learn more about GF Score →
What does a GF Score of 35 mean?
GH Research (FRA:1KA) has a GF Score of 35 as of Jul. 04, 2026. GF Score is a stock performance ranking system developed by GuruFocus using five aspects of valuation. View historical data on GH Research and its competitors. This is 59% above median its historical median of 22.00. Over the past decade, GH Research's GF Score has ranged from 14.00 to 42.00.
Is GH Research's GF Score too high?
GH Research's current GF Score of 35 is 59% above median its 10-year median of 22.00. Over the past 10 years, this metric has ranged from a low of 14.00 to a high of 42.00. Overall, GH Research has a GF Score™ of 35/100, reflecting its overall financial health beyond just this single metric.
How does GH Research's GF Score compare to ATAI and RAPP?
GH Research's GF Score of 35 can be compared against companies in the Biotechnology industry. Historically, GH Research's own GF Score has ranged from 14.00 to 42.00 over the past decade. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good GF Score for a Biotechnology company?
A good GF Score depends on the Biotechnology industry context. However, GF Score should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high GF Score mean?
A high GF Score can signal that a stock is expensive relative to its fundamentals. GF Score is a stock performance ranking system developed by GuruFocus using five aspects of valuation. View historical data on GH Research and its competitors. GH Research's current GF Score is 35, which is 59% above median its own 10-year median of 22.00. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is GH Research stock overvalued right now?
GH Research (FRA:1KA) has a current GF Score of 35. The current GF Score is 35, which is 59% above median its 10-year median of 22.00. GH Research's overall GF Score™ is 35/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is GF Score calculated?
GF Score is calculated from a company's financial statements. For GH Research (FRA:1KA), the current GF Score is 35 as of Jul. 04, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

GH Research Business Description

Other Exchanges GHRS:USA
Address Dawson Street, Joshua Dawson House, Dublin 2, IRL, D02 RY95
GH Research PLC is a clinical-stage biopharmaceutical company dedicated to transforming the lives of patients by developing a practice-changing treatment for depression. Its initial focus is on developing novel and proprietary mebufotenin therapies for the treatment of patients with Treatment-Resistant Depression, or TRD. Its portfolio currently includes GH001, a proprietary inhalable mebufotenin product candidate, and GH002, a proprietary intravenous mebufotenin product candidate. The group has only a single segment: Research and Development.
35GF Score

Get the complete analysis for FRA:1KA

GF Score is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€23.20
Price